SEPTInvestingStart Free
Stocks/XCUR/SEC Filings/8-K Nov 10, 2026

XCUR 8-K: Divestiture

Exicure, Inc. and its subsidiary GPCR Therapeutics USA Inc.

Filed with the SEC on Nov 10, 2026 ยท accession 0001193125-26-455339

XCUR filed a 8-K (current report) with the SEC on Nov 10, 2026. Exicure, Inc. and its subsidiary GPCR Therapeutics USA Inc. entered into an agreement to sell certain assets and rights related to the GPC-100 (burixafor) program to GPCRT Inc. for approximately US$4.8 million in cash. The stock moved +21.3% by the first close after the filing.

Summary of the filing

Exicure, Inc. and its subsidiary GPCR Therapeutics USA Inc. entered into an agreement to sell certain assets and rights related to the GPC-100 (burixafor) program to GPCRT Inc. for approximately US$4.8 million in cash. The transaction is subject to customary closing conditions, including regulatory approvals and stockholder approval.

For details, click here โ†’How to read a 8-K โ†’

Key details

Aggregate purchase price for the Assets$4.8M
Deposit previously paid by PurchaserKRW 500.0M
Interim payment payable on or before November 16, 2026KRW 2.0B
Final payment payable at closingKRW 4.0B
SellerExicure, Inc.
Seller subsidiaryGPCR Therapeutics USA Inc.
PurchaserGPCRT Inc.

How XCUR stock reacted

Close before

$0.89

Nov 9, 2026

First close after

+21.31%

$1.08

5 trading days

โ€”

Since filing

โ€”

โœฆ Ask GOAX AI about this filing โ€” what it means for XCUR, what changed since its last filings and what to watch next.

Try it free for 7 days

๐Ÿ”” Want to stay updated on new SEC filings for XCUR?

Click here

Frequently asked questions

What did XCUR file with the SEC on Nov 10, 2026?

XCUR filed a 8-K (Divestiture). Exicure, Inc. and its subsidiary GPCR Therapeutics USA Inc. entered into an agreement to sell certain assets and rights related to the GPC-100 (burixafor) program to GPCRT Inc. for approximately US$4.8 million in cash. The transaction is subject to customary closing conditions, including regulatory approvals and stockholder approval.

What does a divestiture mean for XCUR stock?

A contract important enough that investors need to know about it โ€” a big customer contract, a loan, a merger agreement or a partnership.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value โ€” results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did XCUR stock react to this filing?

XCUR closed at $0.89 before the filing and $1.08 on Nov 10, 2026 (+21.31%).

Other XCUR SEC filings

  • 8-K ยท SEC filingSep 16, 2026
  • 10-Q ยท SEC filingAug 14, 2026
  • 8-K ยท SEC filingJun 30, 2026
  • 8-K ยท Delisting noticeJun 1, 2026
  • 10-Q ยท SEC filingMay 29, 2026
  • NT 10-Q ยท Late filingMay 15, 2026

Get alerts when XCUR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
XCUR overviewXCUR analysisXCUR newsLatest SEC filings
Source: SEC EDGAR filing 0001193125-26-455339. The summary and key details are extracted by SEPT from the filing and may contain errors. Price reaction uses daily closing prices. Not financial advice.